ROCKET PHARMACEUTICALS, INC.RCKTEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing first-in-class adeno-associated virus (AAV) and lentiviral-based gene therapies for rare, orphan genetic disorders with high unmet medical need. It primarily operates across the U.S. and European markets, with pipeline candidates targeting hematologic, neurological, and pediatric genetic conditions.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| RTW Investments, LP | 17.40% | 18.2M | ▼ -2.81pp | 2024-12-16 |
| Wellington Management Group LLP | 12.36% | 11.2M | ▲ +2.24pp | 2024-11-08 |
| BlackRock, Inc. | 6.60% | 5.9M | — | 2024-01-29 |
| The Vanguard Group | 6.04% | 5.4M | — | 2024-02-13 |
| STATE STREET CORPORATION | 3.58% | 77.3K | — | 2024-01-22 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.